Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBP) Change in Receivables (2017 - 2025)

Historic Change in Receivables for Regen BioPharma (RGBP) over the last 8 years, with Q4 2025 value amounting to $27425.0.

  • Regen BioPharma's Change in Receivables changed 0.36% to $27425.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $110001.0, marking a year-over-year change of 0.09%. This contributed to the annual value of $110000.0 for FY2025, which is 1594.33% up from last year.
  • Latest data reveals that Regen BioPharma reported Change in Receivables of $27425.0 as of Q4 2025, which was up 0.36% from $27726.0 recorded in Q3 2025.
  • Regen BioPharma's 5-year Change in Receivables high stood at $27726.0 for Q3 2021, and its period low was -$122575.0 during Q4 2022.
  • Over the past 5 years, Regen BioPharma's median Change in Receivables value was $27424.5 (recorded in 2021), while the average stood at $5084.2.
  • As far as peak fluctuations go, Regen BioPharma's Change in Receivables plummeted by 54694.62% in 2022, and later skyrocketed by 22148.39% in 2024.
  • Over the past 5 years, Regen BioPharma's Change in Receivables (Quarter) stood at $27425.0 in 2021, then tumbled by 546.95% to -$122575.0 in 2022, then surged by 110.03% to $12298.0 in 2023, then soared by 123.0% to $27424.0 in 2024, then rose by 0.0% to $27425.0 in 2025.
  • Its Change in Receivables was $27425.0 in Q4 2025, compared to $27726.0 in Q3 2025 and $27427.0 in Q2 2025.